Holy Haid

Holy Haid Artificial Intelligence Drug Research and Development Co., Ltd. is the world's first integrated platform for artificial intelligence-driven new drug research, development, and incubation. Focused on hepatitis B in China, it has established an entirely new model for new drug R&D. With a globally unique drug discovery platform based on the Thunder AI R&D platform, the China-Israel Joint Think Tank, and the Hepatitis B Real-World Data (RWD) platform, the company has multiple pipeline products under development aimed at achieving functional cures for hepatitis B. The company has filed over 50 patent applications covering all dimensions including drugs, indications, and AI technology, creating a comprehensive patent barrier. The management team brings together top scientists from China, the United States, and Israel, spanning expertise from micro-biochemistry to real-world clinical applications of hepatitis B, forming the most extensive hepatitis B R&D team.